199 related articles for article (PubMed ID: 34237958)
41. The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major.
Carnevale A; Pellegrino F; Bravi B; Gamberini MR; Gagliardi I; Reverberi R; Zatelli MC; Giganti M; Ambrosio MR
Eur J Haematol; 2022 Dec; 109(6):648-655. PubMed ID: 36000276
[TBL] [Abstract][Full Text] [Related]
42. Bone Mineral Density in Adult Patients with Type 1 Diabetes Mellitus Assessed by Both DXA and QCT.
Barmpa E; Karamagkiolis S; Tigas S; Navrozidou P; Vlychou M; Fezoulidis I; Koukoulis GN; Bargiota A
J Diabetes Res; 2023; 2023():8925956. PubMed ID: 37362256
[TBL] [Abstract][Full Text] [Related]
43. Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT.
Yu EW; Thomas BJ; Brown JK; Finkelstein JS
J Bone Miner Res; 2012 Jan; 27(1):119-24. PubMed ID: 21915902
[TBL] [Abstract][Full Text] [Related]
44. Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS).
Vanderschueren D; Pye SR; O'Neill TW; Lee DM; Jans I; Billen J; Gielen E; Laurent M; Claessens F; Adams JE; Ward KA; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Pendleton N; Punab M; Wu FC; Boonen S;
J Clin Endocrinol Metab; 2013 Mar; 98(3):995-1005. PubMed ID: 23386642
[TBL] [Abstract][Full Text] [Related]
45. Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.
Juhász B; Gulyás K; Horváth Á; Pethő Z; Bhattoa HP; Váncsa A; Szekanecz É; Horváth C; Kocsis J; Horváth Z; Hodosi K; Szántó S; Szűcs G; Szekanecz Z
Osteoporos Int; 2017 Apr; 28(4):1271-1277. PubMed ID: 27942777
[TBL] [Abstract][Full Text] [Related]
46. A comparison of spinal quantitative computed tomography with dual energy X-ray absorptiometry in European women with vertebral and nonvertebral fractures.
Bergot C; Laval-Jeantet AM; Hutchinson K; Dautraix I; Caulin F; Genant HK
Calcif Tissue Int; 2001 Feb; 68(2):74-82. PubMed ID: 11310350
[TBL] [Abstract][Full Text] [Related]
47. Changes in bone mass and bone turnover following ankle fracture.
Ingle BM; Hay SM; Bottjer HM; Eastell R
Osteoporos Int; 1999; 10(5):408-15. PubMed ID: 10591839
[TBL] [Abstract][Full Text] [Related]
48. Does Baseline PTH Influence Recovery of Bone Mineral Density, Trabecular Bone Score and Bone Turnover Markers? A Prospective Study Following Curative PArathyroidectomy in Primary Hyperparathyroidism.
Shetty S; Cherian KE; Shetty S; Kapoor N; Jebasingh FK; Cherian A; Hephzibah J; Chandramohan A; John RA; Asha HS; Paul MJ; Manipadam MT; Abraham DT; Thomas N; Paul TV
Endocr Pract; 2020 Dec; 26(12):1442-1450. PubMed ID: 33471736
[TBL] [Abstract][Full Text] [Related]
49. Thalassemic osteopathy: a new marker of bone deposition.
Baldini M; Forti S; Orsatti A; Marcon A; Ulivieri FM; Airaghi L; Zanaboni L; Cappellini MD
Blood Cells Mol Dis; 2014; 52(2-3):91-4. PubMed ID: 24091145
[TBL] [Abstract][Full Text] [Related]
50. Improved prediction of incident vertebral fractures using opportunistic QCT compared to DXA.
Löffler MT; Jacob A; Valentinitsch A; Rienmüller A; Zimmer C; Ryang YM; Baum T; Kirschke JS
Eur Radiol; 2019 Sep; 29(9):4980-4989. PubMed ID: 30790025
[TBL] [Abstract][Full Text] [Related]
51. QCT versus DXA in 320 survivors of childhood cancer: association of BMD with fracture history.
Kaste SC; Tong X; Hendrick JM; Karimova EJ; Srivastava DK; Tylavsky FA; Snider TL; Carbone LD
Pediatr Blood Cancer; 2006 Dec; 47(7):936-43. PubMed ID: 16602115
[TBL] [Abstract][Full Text] [Related]
52. Relationships between anthropometric adiposity indexes and bone mineral density in a cross-sectional Chinese study.
Deng G; Yin L; Li K; Hu B; Cheng X; Wang L; Zhang Y; Xu L; Xu S; Zhu L; Shao J; Hao X; Zhou J; Tang J; Li W; Jiang Y; Cheng X
Spine J; 2021 Feb; 21(2):332-342. PubMed ID: 33091612
[TBL] [Abstract][Full Text] [Related]
53. Mineral bone disorder and osteoporosis in hemodialysis patients.
Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
[TBL] [Abstract][Full Text] [Related]
54. Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.
Lewiecki EM; Keaveny TM; Kopperdahl DL; Genant HK; Engelke K; Fuerst T; Kivitz A; Davies RY; Fitzpatrick LA
J Clin Endocrinol Metab; 2009 Jan; 94(1):171-80. PubMed ID: 18840641
[TBL] [Abstract][Full Text] [Related]
55. Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women.
Yu W; Glüer CC; Fuerst T; Grampp S; Li J; Lu Y; Genant HK
Calcif Tissue Int; 1995 Sep; 57(3):169-74. PubMed ID: 8574931
[TBL] [Abstract][Full Text] [Related]
56. The Positive Relationship Between the Low-Density Lipoprotein Cholesterol/Apoprotein B Ratio and Bone Turnover Markers in Patients With Type 2 Diabetes.
Lu CF; Liu WS; Huang HY; Ge XQ; Hua LY; Wang XQ; Su JB
Front Endocrinol (Lausanne); 2022; 13():903336. PubMed ID: 35757416
[TBL] [Abstract][Full Text] [Related]
57. Combining information from multiple bone turnover markers as diagnostic indices for osteoporosis using support vector machines.
Zhang T; Liu P; Zhang Y; Wang W; Lu Y; Xi M; Duan S; Guan F
Biomarkers; 2019 Mar; 24(2):120-126. PubMed ID: 30442069
[TBL] [Abstract][Full Text] [Related]
58. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
Shou Z; Jin X; Bian P; Li X; Chen J
Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
[TBL] [Abstract][Full Text] [Related]
59. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
[TBL] [Abstract][Full Text] [Related]
60. [Clinical value of serum total P1NP, β-CTX and 25(OH)D3 detection in evaluating risks of fragile hip fracture in elderly patients with osteoporosis].
Lou H; Peng C; Chen Q
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1346-9. PubMed ID: 22985580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
